American International Group’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-27,923
| Closed | -$1.07M | – | 3079 |
|
|
2023
Q2 | $1.07M | Buy |
27,923
+3,456
| +14% | +$88.7K | 0.01% | 1210 |
|
|
2023
Q1 | $566K | Buy |
24,467
+487
| +2% | +$11.6K | ﹤0.01% | 1523 |
|
|
2022
Q4 | $628K | Buy |
23,980
+306
| +1% | +$6.78K | ﹤0.01% | 1467 |
|
|
2022
Q3 | $465K | Buy |
23,674
+3,229
| +16% | +$64.8K | ﹤0.01% | 1630 |
|
|
2022
Q2 | $358K | Buy |
20,445
+416
| +2% | +$6.53K | ﹤0.01% | 1813 |
|
|
2022
Q1 | $328K | Sell |
20,029
-737
| -4% | -$10K | ﹤0.01% | 1962 |
|
|
2021
Q4 | $339K | Buy |
20,766
+2,645
| +15% | +$37.7K | ﹤0.01% | 2056 |
|
|
2021
Q3 | $231K | Buy |
18,121
+499
| +3% | +$6.57K | ﹤0.01% | 2349 |
|
|
2021
Q2 | $249 | Buy |
17,622
+9,884
| +128% | +$158K | ﹤0.01% | 2369 |
|
|
2021
Q1 | $120 | Buy |
7,738
+21
| +0.3% | +$342 | ﹤0.01% | 2622 |
|
|
2020
Q4 | $122 | Sell |
7,717
-222
| -3% | -$3.35K | ﹤0.01% | 2559 |
|
|
2020
Q3 | $97K | Sell |
7,939
-181
| -2% | -$2.43K | ﹤0.01% | 2558 |
|
|
2020
Q2 | $94K | Buy |
8,120
+365
| +5% | +$5.03K | ﹤0.01% | 2572 |
|
|
2020
Q1 | $106K | Sell |
7,755
-448
| -5% | -$5.3K | ﹤0.01% | 2273 |
|
|
2019
Q4 | $48K | Sell |
8,203
-69
| -0.8% | -$375 | ﹤0.01% | 2893 |
|
|
2019
Q3 | $44K | Sell |
8,272
-58
| -0.7% | -$385 | ﹤0.01% | 2924 |
|
|
2019
Q2 | $64K | Buy |
8,330
+148
| +2% | +$2.25K | ﹤0.01% | 2882 |
|
|
2019
Q1 | $163K | Sell |
8,182
-265
| -3% | -$4.62K | ﹤0.01% | 2326 |
|
|
2018
Q4 | $111K | Sell |
8,447
-65
| -0.8% | -$1.3K | ﹤0.01% | 2536 |
|
|
2018
Q3 | $313K | Buy |
8,512
+154
| +2% | +$4.94K | ﹤0.01% | 2150 |
|
|
2018
Q2 | $293K | Buy |
8,358
+2,602
| +45% | +$99.8K | ﹤0.01% | 2150 |
|
|
2018
Q1 | $268K | Sell |
5,756
-309
| -5% | -$11.3K | ﹤0.01% | 2097 |
|
|
2017
Q4 | $227K | Buy |
6,065
+606
| +11% | +$26.5K | ﹤0.01% | 2250 |
|
|
2017
Q3 | $291K | Buy |
5,459
+408
| +8% | +$24.2K | ﹤0.01% | 2064 |
|
|
2017
Q2 | $288K | Buy |
5,051
+683
| +16% | +$34.3K | ﹤0.01% | 2052 |
|
|
2017
Q1 | $235K | Buy |
4,368
+289
| +7% | +$16.3K | ﹤0.01% | 2084 |
|
|
2016
Q4 | $232K | Sell |
4,079
-10
| -0.2% | -$605 | ﹤0.01% | 2089 |
|
|
2016
Q3 | $254K | Buy |
4,089
+6
| +0.1% | +$424 | ﹤0.01% | 2013 |
|
|
2016
Q2 | $231K | Buy |
4,083
+3,105
| +317% | +$189K | ﹤0.01% | 2042 |
|
|
2016
Q1 | $63K | Hold |
978
| – | – | ﹤0.01% | 3741 |
|
|
2015
Q4 | $138K | Sell |
978
-1
| -0.1% | -$136 | ﹤0.01% | 3205 |
|
|
2015
Q3 | $95K | Buy |
979
+1
| +0.1% | +$119 | ﹤0.01% | 3528 |
|
|
2015
Q2 | $148K | Buy |
+978
| New | +$161K | ﹤0.01% | 3297 |
|
American International Group's KDNY Position: Q3 2023 in Review
American International Group sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 27,923 shares — an estimated $1.07M sold.
American International Group first reported a position in KDNY in Q2 2015 and held it in 33 quarters. The position peaked at $1.07M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- American International Group reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- American International Group sold 27,923 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.07M.
- American International Group first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 33 quarters.
- American International Group's Chinook Therapeutics, Inc. Common Stock position peaked at $1.07M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on American International Group's 13F filing for Q3 2023, filed 13 Nov 2023.